SIGIRR
Single Ig IL-1-related receptor
Also known as: IL-1R8, SIGIR_HUMAN, TIR8
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6IA17
- Gene
- SIGIRR
- Ensembl
- ENSG00000185187
- Chromosome
- 11
- Canonical length
- 410 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoli fibrillar center,Cytosol
OverviewNCBI Gene
Involved in negative regulation of Toll signaling pathway. Located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
410 residues, UniProt reviewed canonical sequence.
>Q6IA17|SIGIRR
1 MPGVCDRAPD FLSPSEDQVL RPALGSSVAL NCTAWVVSGP HCSLPSVQWL KDGLPLGIGG
61 HYSLHEYSWV KANLSEVLVS SVLGVNVTST EVYGAFTCSI QNISFSSFTL QRAGPTSHVA
121 AVLASLLVLL ALLLAALLYV KCRLNVLLWY QDAYGEVEIN DGKLYDAYVS YSDCPEDRKF
181 VNFILKPQLE RRRGYKLFLD DRDLLPRAEP SADLLVNLSR CRRLIVVLSD AFLSRAWCSH
241 SFREGLCRLL ELTRRPIFIT FEGQRRDPAH PALRLLRQHR HLVTLLLWRP GSVTPSSDFW
301 KEVQLALPRK VQYRPVEGDP QTQLQDDKDP MLILRGRVPE GRALDSEVDP DPEGDLGVRG
361 PVFGEPSAPP HTSGVSLGES RSSEVDVSDL GSRNYSARTD FYCLVSKDDMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SIGIRR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 90 nTPM
Expression across tissuesHPA
Tissue
- liver: 90 nTPM
- spleen: 68 nTPM
- kidney: 66 nTPM
- pancreas: 45 nTPM
- small intestine: 45 nTPM
- colon: 43 nTPM
Single-cell type
- hepatocytes: 451 nCPM
- melanocytes: 151 nCPM
- colonocytes: 131 nCPM
- tuft cells: 127 nCPM
- fallopian tube ciliated cells: 117 nCPM
- epididymal principal cells: 106 nCPM
Immune cell
- gdT-cell: 124 nTPM
- memory CD8 T-cell: 108 nTPM
- T-reg: 106 nTPM
- NK-cell: 103 nTPM
- memory CD4 T-cell: 102 nTPM
- MAIT T-cell: 99 nTPM
Brain region
- medulla oblongata: 28 nTPM
- pons: 26 nTPM
- white matter: 21 nTPM
- thalamus: 20 nTPM
- spinal cord: 18 nTPM
- midbrain: 17 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.05
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- acute-phase response
- cell surface receptor signaling pathway
- negative regulation of chemokine production
- negative regulation of cytokine-mediated signaling pathway
- negative regulation of interleukin-1-mediated signaling pathway
- negative regulation of lipopolysaccharide-mediated signaling pathway
- negative regulation of Toll signaling pathway
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SIGIRR in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SIGIRR as an antibody target. Whether an autoantibody or antibody against SIGIRR could matter depends on whether native SIGIRR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SIGIRR is annotated at the cell surface, where native SIGIRR is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SIGIRR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...